Aditxt’s Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at ...
Researchers at UTHealth Houston are transforming skin cells into miniature brains to study schizophrenia and other mental ...
DRESDEN, Germany & LEXINGTON, Mass.--(BUSINESS WIRE)--Seamless Therapeutics today announced that it will be presenting new preclinical data, including human cell data, highlighting its unique platform ...
GITEX GLOBAL 2025 concluded its 45th edition following a remarkable surge of deal-making and breakthrough unveilings spanning AI, data infrastructure, cybersecurity, quantum, digital health, and ...
Resting brain stem cells hardly differ from normal astrocytes, which support the nerve cells in the brain. How can almost identical cells perform such different functions? The key lies in the ...
Plans to seek FDA submission and approval for first-in-human trials in type 1 diabetes and stiff person syndrome targeted for early 2026 MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Aditxt, Inc. (NASDAQ: ...
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt”, or the “Company”), a social innovation platform accelerating promising health innovations, today announced an update on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback